Work

Pacritinib in patients with high-risk myelofibrosis: Outcomes from post-hoc analyses of two Phase 3 studies

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2019

Authors: Pankit Vachhani, Nikolai Podoltsev, Ashwin Kishtagari, Purvi Suthar, Michael Vredenburg, Karisse Roman-Torres, Aaron Gerds

Institutions: University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Yale University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Cleveland Clinic

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417019032

Cites:

Cited by:

Related to: